22. Drug Action on Ion Channels and Pumps Flashcards

1
Q

Describe what is happening at Phase 0, 2, and 3.

A

Phase 0 - the rapid depolarization phase caused by influx of Na+
Phase 2 - repolarization caused by efflux of K+ but balanced by influx of Ca2+ –> remains horizontal line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain what the responsibility of NAv1.5 is.

A

NAv1.5 is the voltage-gated Na+ channel that is responsible for intial upstroke of action potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Identify what maintains the resting potential.

A

Na+-K+ pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the effective refractory period (ERP).

A

ERP is the period in time, in which a new action potential cannot be initiated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify the 4 classes of antiarrhythmic agents.

A

Class 1 - Na+ channel blockers
Class 2 - beta blockers
Class 3 - K+ channel blockers
Class 4 - Ca2+ channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how the strength of the inhibitor is going to effect the initial Phase 0.

A

Inital phase 0 slope is decreased more as the inhibitor gets stronger.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rank the kinetic strength of class 1 antiarrhythmic agents: Na+ channel blockers from strongest to weakest.

A

Class 1B (strongest - fast kinetics)
* Lidocaine, phenytoin
* decreases ERP

**Class 1A **
* Quinidine, procainamide
* increases ERP

Class 1C (weakest - slowest kinetics)
* flecainide, propafenone
* maintains ERP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain how Na+ channel blockers can work as antiepileptic agents.
Give examples.

A

By blocking the voltage-gated Na+ channels, there is no influx of Na+ into the neuronal membranes.
–> results in decreased axonal conduction by increasing the ERP of the neuron
* Phenytoin, carbamazepine, oxcarbazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Can Na+ channel blockers be used as local anesthetic agents?

A

Yes! They can be short, medium, or high duration anesthetics.
Short - low potency - procaine, chloroprocaine
medium duration potency - lidocaine, prilocaine
high duration potency - tetracaine, bupivacaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the three drug actions on sodium channels.

A
  • antiarrhythmic drugs
  • antiepileptic drugs
  • local anesthetic agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the function of Class 3 antiarrhythmic agents: K+ channel blockers.

A

Primary role: K+ channels are responsible for cell repolarization
* increases phase 3 of the cardiac action potential (delayed repolarization)
* increases ERP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the contribution of Class 3: K+ channel blockers on reducing arrhythmias.

A

K+ channel blockers inhibit the efflux of K+ ions
* increases the period before a new signal for contraction can be generated
* helps correct arrhythmias by reducing the potential for premature/abnormal contraction of the ventricles
* prolongs the frequency of ventricular contraction –> treats tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List drugs that are K+ channel blocker antiarrhythmic agents.

A
  • amiodarone
  • sotalol
  • dofetilide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List drug actions on calcium channels.

A
  • antiarrhythmic drugs
  • antihypertension drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two types of Ca2+ channel blockers and what are they used for. Give examples.

A

Dihydropyridine Ca2+ channel blockers
* antihypertension
* amlodipine, nifedipine, fleodipine

Non-dihydropyridine Ca2+ channel blockers
* antihypertension and antiarrhythmics
* verapamil, diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the role of Class 4: Ca2+ channel blockers.

A
  • primarily present in the SA and AV nodes of the heart
  • decreases the length of phase 2 in the cardiac action potential
  • slows heart rate –> allows left ventricle to fill completely and lowers the heart workload
17
Q

Describe the Na-K pump and its role in membrane potential.

A
  • cells use the Na-K pump to help maintain a negative resting potential and gradients of Na+ and K+
  • 3 Na+ ions leave the cell
  • 2 K+ ions enter the cell
  • each ATP molecule decreases the membrane potential by one charge unit
  • Na-K pump is an active transporter
18
Q

Describe the mode of action of Ouabain.

A

Ouabin is a natural toxin that acts by inhibiting the Na-K pump.
* cardiac glycoside and can be used to treat hypotension and some arrhythmias in low doses

19
Q

Describe how digoxin works as a Na-K pump inhibitor.

A

Used to treat various heart conditions
* inhibits the Na-K pump in the myocardium
* inhibition causes an increase in intracellular Na+ –> decreased activity of the Na-Ca2+ exchanger
* high intracellular Na+ causes Na-Ca2+ exchanger to pump IN Ca2+ and OUT Na+ –> increase Ca2+ concentration in cell
* result: decreased heart rate bc it contracts stronger

20
Q

What are PPIs used for?

A

PPI (proton pump inhibitors) are used to turn off proton pumps and reduce acid production in the stomach
* acids are produced by proton pumps (H+-K+ pumps)
* treats GI diseases: GERD, esophagitis
* drugs: –prazole

21
Q

Explain the mechanism of PPIs.

A
  • PPIs irreversibly bind to H+-K+ pumps.
  • prevents the movement of H+ ions from the parietal cells to the stomach = achlorhydria (all gastric acid secretion is temporarily blocked)
  • to return to normal acid secretion, the parietal cells must create new H+-K+ pumps
22
Q
A

E. propranolol

23
Q
A

A. lidocaine

24
Q
A

E. Flecainide - maintains ERP

25
Q
A

E. Digoxin leads to an increase in heart rate
* digoxin leads to a slower heart rate bc of the stronger contractions

26
Q
A

D. Omeprazole prevents the movement of H+ from the stomach to the parietal cells.